21 days ago
Andy Baehr, GSR's managing director of **** et management, says bitcoin's $80,000 breakout marks a new market regime. He argues the crypto trading firm watched a stagnant summer flip into real momentum within days.
Baehr spent 25 years on Wall Street derivatives desks, including Morgan Stanley and Credit Suisse, before crossing into digital **** ets. He served as the Executive Director of Equity Derivatives at Morgan Stanley between 2006 and 2007.
Bitcoin (BTC) briefly , topping out at $reclaimed $80,000 this week, topping out at $81,272 on Monday. It marked the first time since May that the pioneer crypto tested this threshold.
Baehr had urged patience through what he called a "super slow summer" of thin volumes and muted price action. The stagnation was measurable. Digital **** et funds bled a record $8 billion across eight straight weeks of ETF withdrawals before demand returned.
Then the mood turned fast. News of Treasury buybacks in long-dated bonds arrived alongside a planned White House gathering of crypto executives. Industry leaders were meeting in Jackson Hole as the headlines hit, Baehr recalled.
#Crypto #morgan #derivatives #digital
Baehr spent 25 years on Wall Street derivatives desks, including Morgan Stanley and Credit Suisse, before crossing into digital **** ets. He served as the Executive Director of Equity Derivatives at Morgan Stanley between 2006 and 2007.
Bitcoin (BTC) briefly , topping out at $reclaimed $80,000 this week, topping out at $81,272 on Monday. It marked the first time since May that the pioneer crypto tested this threshold.
Baehr had urged patience through what he called a "super slow summer" of thin volumes and muted price action. The stagnation was measurable. Digital **** et funds bled a record $8 billion across eight straight weeks of ETF withdrawals before demand returned.
Then the mood turned fast. News of Treasury buybacks in long-dated bonds arrived alongside a planned White House gathering of crypto executives. Industry leaders were meeting in Jackson Hole as the headlines hit, Baehr recalled.
#Crypto #morgan #derivatives #digital
1 month ago
Gayn Erickson, President and Chief Executive Officer of Aehr Test Systems, Inc. (NASDAQ:AEHR), sold 40,000 shares of common stock on August 12, 2026, as disclosed in a recent SEC Form 4 filing.
Metric
Value
Transaction value
$5.2 million
#aehr #value #executive #test
Metric
Value
Transaction value
$5.2 million
#aehr #value #executive #test
1 month ago
Jefferies initiated AEHR with a Buy rating and $175 target, calling its model conservative and excluding memory wins and AI customer upside.
COHU gained 151% and TER rose 112% year to date as AI chip complexity drives demand for more intensive semiconductor testing.
AEHR carries extreme valuation risk with a beta of 3.09, a recent 43% YoY revenue drop, and steady CEO and CFO insider selling.
Don't wait: the ****** yst who called NVIDIA in 2010 just revealed his top 10 AI stocks. See the full list FREE now.
Shares of Aehr Test Systems (NASDAQ:AEHR) are up roughly 8% in Friday midday, after a fresh Wall Street initiation lit another fire under one of 2026's most explosive small caps. The move extends a year-to-date advance of 510.7% and pushes the stock through its 52-week high of $133.35.
#date #free
COHU gained 151% and TER rose 112% year to date as AI chip complexity drives demand for more intensive semiconductor testing.
AEHR carries extreme valuation risk with a beta of 3.09, a recent 43% YoY revenue drop, and steady CEO and CFO insider selling.
Don't wait: the ****** yst who called NVIDIA in 2010 just revealed his top 10 AI stocks. See the full list FREE now.
Shares of Aehr Test Systems (NASDAQ:AEHR) are up roughly 8% in Friday midday, after a fresh Wall Street initiation lit another fire under one of 2026's most explosive small caps. The move extends a year-to-date advance of 510.7% and pushes the stock through its 52-week high of $133.35.
#date #free
2 months ago
Aehr Test Systems (NASDAQ:AEHR) and C3.ai (NYSE:AI) both aim to capitalize on the artificial intelligence boom, but they operate on opposite ends of the technological spectrum. Which is the better buy?
Aehr focuses on the hardware side, providing essential testing equipment for chips used in high-growth markets like electric vehicles and data centers. C3.ai provides the software layer, helping massive organizations deploy predictive artificial intelligence applications. Both companies are navigating a shifting landscape where rapid innovation meets lumpy revenue cycles.
Aehr Test Systems designs and sells specialized equipment used to test chips at the wafer level to identify defects before they reach final ***** embly. The company is a niche player among semiconductor stocks, providing essential testing equipment for silicon carbide chips. Customer concentration like this adds a layer of risk to the business, as its five largest customers accounted for roughly 70% of net revenues in fiscal 2026.
In FY 2026, revenue reached close to $50.0 million, representing a decline of approximately 15.2% compared to the previous year. This revenue drop contributed to a net loss of roughly $7.1 million for the period. The net margin, which shows how much of each dollar earned becomes profit after all expenses, was nearly -14.3%.
As of its May 2026 balance sheet, the company maintains a current ratio of approximately 10.3x. The current ratio measures a firm's ability to cover short-term debts with short-term ***** ets, with a higher number generally suggesting better liquidity. The debt-to-equity ratio is roughly 0.0x, indicating the company holds negligible debt relative to its shareholder equity while free cash flow was nearly -$5.4 million.
#test #ratio
Aehr focuses on the hardware side, providing essential testing equipment for chips used in high-growth markets like electric vehicles and data centers. C3.ai provides the software layer, helping massive organizations deploy predictive artificial intelligence applications. Both companies are navigating a shifting landscape where rapid innovation meets lumpy revenue cycles.
Aehr Test Systems designs and sells specialized equipment used to test chips at the wafer level to identify defects before they reach final ***** embly. The company is a niche player among semiconductor stocks, providing essential testing equipment for silicon carbide chips. Customer concentration like this adds a layer of risk to the business, as its five largest customers accounted for roughly 70% of net revenues in fiscal 2026.
In FY 2026, revenue reached close to $50.0 million, representing a decline of approximately 15.2% compared to the previous year. This revenue drop contributed to a net loss of roughly $7.1 million for the period. The net margin, which shows how much of each dollar earned becomes profit after all expenses, was nearly -14.3%.
As of its May 2026 balance sheet, the company maintains a current ratio of approximately 10.3x. The current ratio measures a firm's ability to cover short-term debts with short-term ***** ets, with a higher number generally suggesting better liquidity. The debt-to-equity ratio is roughly 0.0x, indicating the company holds negligible debt relative to its shareholder equity while free cash flow was nearly -$5.4 million.
#test #ratio
2 months ago
Shares in Aehr Test Systems Inc. (NASDAQ:AEHR) jumped by 11.6 percent week-on-week, as investors increased their exposure after management posted a highly optimistic outlook for fiscal year 2027, thanks to the continued strong demand for semiconductor testing.
In an updated report last week, the company said that it is targeting to grow its revenues during the period by 160 to 200 percent to a range of $130 million to $150 million, versus the $50 million posted last year, supported by a $100 million effective backlog.
For illustration purposes only. Photo by Sergei Starostin on Pexels
The upbeat guidance overshadowed its weak performance in the full fiscal year of 2026, with net losses wider by 82 percent to $7.1 million versus $3.9 million in fiscal year 2025.
The full-year loss primarily reflected higher losses in the first three quarters of the year, which more than offset the strong recovery in the fourth quarter.
In an updated report last week, the company said that it is targeting to grow its revenues during the period by 160 to 200 percent to a range of $130 million to $150 million, versus the $50 million posted last year, supported by a $100 million effective backlog.
For illustration purposes only. Photo by Sergei Starostin on Pexels
The upbeat guidance overshadowed its weak performance in the full fiscal year of 2026, with net losses wider by 82 percent to $7.1 million versus $3.9 million in fiscal year 2025.
The full-year loss primarily reflected higher losses in the first three quarters of the year, which more than offset the strong recovery in the fourth quarter.
